When eyeforpharma Philadelphia 2017 kicks off on April 20, it will offer attendees six in-depth commercial pharma tracks, each focused on a different industry issue. The conference, now in its 15th year, features sessions by more than 50 executive-level thought leaders in just two days.
With that kind of schedule, it’s impossible to see everything. That’s why we sat down with DMD’s Chief Product Officer David Reim to learn his recommended not-to-miss sessions:
DAY ONE - April 20, 2017
Delivering Impact through Customer-Centric Partnerships
Partap Khedkar & Paul Darling, principals, ZS Associates
11:00 a.m. – 11:30 a.m., Blue Room
"At DMD, our job is to collect as much raw data as we can. Then we work closely with industry colleagues – including Partap and Paul at ZS Associates – who process it, turning data into valuable insight for marketers. ZS Associates have worked to pioneer data analytics in pharma. They’ve also been leaders in the philosophy of customer-centricity, not focusing solely on HCPs. Patient-centric marketing partnerships are proving their efficacy - so a keynote from some of the leading insight generators in the business will definitely be worth attending."
Digital Transformation from the Inside Out and Upside Down
Will Reese, President Cadient & Chief Innovation Officer, Cognizant Life Sciences
5:10 p.m. – 5:40 p.m., Yellow Rooom
"Although this session is at the end of the day, it is definitely one not to miss. I’ve known Will for nearly 20 years, and he’s a true industry veteran. Digital transformation is ongoing, no company is ever done transforming, and so no matter where your organization is in the spectrum of digital adoption, you’ll pick up some good advice and some helpful tips from Will during this session."
DAY TWO - April 21, 2017
Maximize the capabilities of your commercial teams through a greater understanding of Analytics, CRM and CLM
Laura Barry, Senior Director Customer Insights, Analytics and Experiences, Abbvie
9:55 a.m. – 10:20 a.m., Red Room
"DMD’s input, whether it’s authenticated email addresses or digital activity data, is key to the next generation of CRM and analytic systems. This session will be a good look at how data can inform and strengthen strategies around segmentation and personalization. Data revolutionizes these things; instead of having to guess who your target is and hope that you personalize it in the right way, audience identity management (AIM) now allows you to identify that person specifically. So, with AIM, pharma marketers can do the things that Laura is suggesting with more precision to take marketing efforts to the next level."
[Panel] A holistic commercial view: integrate your sales and marketing teams in order to achieve true commercial excellence
Chris Sellin, Head of Operational Excellence & Analytics, Shire
William King, Founder, Zephyr Health
Heather Dean, National Head- Specialty Sales & Accounts, Takeda Pharmaceuticals USA
10:40 a.m. – 11:20 a.m., Yellow Room
"The optimal commercial model depends a lot on the organization and the stage of the products in that organization, but technology and data can help drive that. This panel is a lineup of industry veterans, but William King in particular is well worth hearing. DMD has worked with Zephyr Health on various projects. They have outstanding software that takes in an extraordinary amount of data – including AIM data – to generate unique views of customers and the best methods for approaching them."
And of course…
"I welcome you to my own presentation, Identifying HCP’s by Name at Your Website. In this session I’ll present data from a range of pharma sites who are answering the age-old question: What happens when your website visitors are no longer anonymous? Join me on April 20 from 3:40 PM to 4:10 PM in the Yellow Room.
This conference promises to be exciting and full of relevant and up-to-date information. I’m excited and looking forward to it. See you there!"